Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Blood|August 1, 1980
The effect of oxidant stress on human lymphocyte cytotoxicityM R Grever, V N Thompson, S P Balcerzak, et al.
Transplantation Proceedings|February 1, 1987
A murine model for pharmacological marrow purgingE A Copelan, S C Johnson, M R Grever, et al.
Seminars in Oncology|October 26, 2000
Novel therapies for chronic lymphocytic leukemia in the 21st centuryJ C Byrd, J K Waselenko, M Keating, et al.
Cancer Treatment Reports|September 1, 1984
Phase I trial of teroxironeJ A Neidhart, D Derocher, M R Grever, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Immunosuppressive effects of pentostatinE H Kraut, J C Neff, B A Bouroncle, et al.
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemiaJ K Waselenko, M R Grever, M Beer, et al.
Cancer Research|October 15, 1990
Immunological effects of flavone acetic acidP L Triozzi, J J Rinehart, L Malspeis, et al.
Journal of the National Cancer Institute|May 18, 1988
Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion scheduleJ M Leiby, M R Grever, A E Staubus, et al.
Blood|February 1, 1983
An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphomaM R Grever, E Bisaccia, D A Scarborough, et al.
Blood|June 1, 1988
Pharmacologic marrow purging in murine T cell leukemiaE A Copelan, S C Johnson, M R Grever, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Blood|August 1, 1980
The effect of oxidant stress on human lymphocyte cytotoxicityM R Grever, V N Thompson, S P Balcerzak, et al.
Transplantation Proceedings|February 1, 1987
A murine model for pharmacological marrow purgingE A Copelan, S C Johnson, M R Grever, et al.
Seminars in Oncology|October 26, 2000
Novel therapies for chronic lymphocytic leukemia in the 21st centuryJ C Byrd, J K Waselenko, M Keating, et al.
Cancer Treatment Reports|September 1, 1984
Phase I trial of teroxironeJ A Neidhart, D Derocher, M R Grever, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Immunosuppressive effects of pentostatinE H Kraut, J C Neff, B A Bouroncle, et al.
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemiaJ K Waselenko, M R Grever, M Beer, et al.
Cancer Research|October 15, 1990
Immunological effects of flavone acetic acidP L Triozzi, J J Rinehart, L Malspeis, et al.
Journal of the National Cancer Institute|May 18, 1988
Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion scheduleJ M Leiby, M R Grever, A E Staubus, et al.
Blood|February 1, 1983
An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphomaM R Grever, E Bisaccia, D A Scarborough, et al.
Blood|June 1, 1988
Pharmacologic marrow purging in murine T cell leukemiaE A Copelan, S C Johnson, M R Grever, et al.
Pageof 10